Connect Biopharma Holdings (CNTB) Price to Book (2021 - 2026)

Connect Biopharma Holdings has disclosed Price to Book across 6 years of filings, most recently posting 5.58 for Q2 2026.

• In Q2 2026, Price to Book rose 630.83% year-over-year to 5.58; the TTM figure through Jun 2026 stood at 5.58 (up 630.83% YoY), while the FY2025 annual figure was 3.79, up 357.5% from the prior year.
• Price to Book came in at 5.58 for Q2 2026 at Connect Biopharma Holdings, up from 3.85 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 5.58 in Q2 2026 to a low of 0.22 in Q2 2022.
• Average Price to Book over 5 years is 1.5, with a median of 0.78 recorded in 2025.
• Year-over-year, Price to Book slumped 70.28% in 2022 and surged 949.69% in 2026.
• Over 5 years, Price to Book stood at 0.31 in 2022, then soared by 106.32% to 0.64 in 2023, then increased by 29.36% to 0.83 in 2024, then jumped by 357.5% to 3.79 in 2025, then jumped by 47.17% to 5.58 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 5.58 in Q2 2026, 3.85 in Q1 2026, and 3.79 in Q4 2025.